U.S. Office REITs Stock News

NasdaqGS:STX
NasdaqGS:STXTech

Should Seagate’s Major Debt Exchange Amid Record Storage Performance Require Action From Seagate Technology (STX) Investors?

Seagate Technology Holdings recently completed the exchange of US$600.00 million principal amount of its 3.50% Exchangeable Senior Notes due 2028 for approximately US$599.20 million in cash and 5,952,309 ordinary shares, as part of efforts to reshape its balance sheet. Ahead of this debt exchange, Seagate reported record exabyte shipments and margins for the December quarter, underscoring how balance sheet moves are occurring alongside strong operating performance in mass-capacity...
NasdaqCM:NEO
NasdaqCM:NEOHealthcare

Assessing NeoGenomics (NEO) Valuation After Earnings Growth, Wider Annual Loss And New Guidance

Why NeoGenomics (NEO) is back on investors’ radar NeoGenomics (NEO) recently released fourth quarter and full year 2025 results alongside fresh 2026 guidance, combining revenue growth, a smaller quarterly loss, and a wider full year loss that gives investors more financial clarity. See our latest analysis for NeoGenomics. NeoGenomics’ recent earnings release and 2026 guidance came after a weaker stretch for the stock, with a 30 day share price return of 22.17% and a 1 year total shareholder...
NYSE:CTRA
NYSE:CTRAOil and Gas

Is It Time To Reconsider Coterra Energy (CTRA) After Its Recent Share Price Rally?

If you are wondering whether Coterra Energy is priced attractively at around US$30.75, this article breaks down what the numbers are really saying about the stock’s value. The share price has seen a 12.1% gain over the last 30 days and is up 15.6% year to date, while the 1 year and 5 year returns sit at 13.8% and 110.1% respectively. These changes may have shifted how some investors think about its risk and reward profile. Over the past few months, Coterra has remained in focus as investors...
NYSE:GLW
NYSE:GLWElectronic

Corning (GLW) Is Up 8.8% After Meta Fiber Deal And Springboard Targets - Has The Bull Case Changed?

In recent months, Corning completed a US$2.03 billion share repurchase program, affirmed a quarterly dividend of US$0.28 per share, and outlined ambitious growth targets tied to its Springboard plan and large data center fiber agreements. A key development is Corning’s multi-billion anchor deal with Meta and its focus on Gen AI data center optics, which could meaningfully reshape the company’s business mix toward higher-growth communications infrastructure. We’ll now examine how Corning’s...
NasdaqGS:EXC
NasdaqGS:EXCElectric Utilities

Assessing Exelon (EXC) Valuation After Recent Share Price Strength And Long Term Returns

How Exelon’s Recent Performance Might Look to Long Term Investors Exelon (EXC) has drawn fresh attention after a solid run, with the stock showing gains over the month, past 3 months, year to date, and the past year, alongside multi year total returns. For investors, the backdrop includes annual revenue of US$24.258b and net income of US$2.768b, with both revenue and net income growth reported on an annual basis, and a current share price of US$48.20. See our latest analysis for Exelon. The...
NYSE:OII
NYSE:OIIEnergy Services

Oceaneering International Shifts Beyond Oil Services With Robotics And Defense

Oceaneering International (NYSE:OII) is expanding further into robotics and digital solutions, building on its large Subsea Robotics footprint and automation offerings. The company recently secured record-setting government work within its Aerospace & Defense Technologies segment, described as its largest contract win in that area to date. Management is also targeting bolt on M&A focused on technology capabilities, with an eye on offshore renewables and digital automation...
NYSE:SCHW
NYSE:SCHWCapital Markets

Charles Schwab Compliance Report On Epstein Transfers And Investor Risk Outlook

Charles Schwab filed a suspicious activity report with U.S. authorities related to multimillion dollar transfers linked to Jeffrey Epstein. The firm reported the wire activity and subsequently ended its business relationship connected to those transactions. The disclosures raise questions for investors about Schwab's compliance processes, risk controls, and approach to reputational exposure. For investors watching Charles Schwab, ticker NYSE:SCHW, this compliance story sits alongside a...
NYSE:KNSL
NYSE:KNSLInsurance

Assessing Kinsale Capital Group’s Valuation After Strong 2025 Earnings And New US$250 Million Buyback Program

Kinsale Capital Group (KNSL) is back in focus after reporting its fourth quarter and full year 2025 results, alongside a new US$250 million share repurchase plan and continued dividends. See our latest analysis for Kinsale Capital Group. The recent earnings beat, new US$250 million buyback authorization and ongoing dividends come against a softer share price backdrop, with a 30 day share price return of an 8.36% decline and a 1 year total shareholder return of a 12.61% decline, while the 5...
NYSE:V
NYSE:VDiversified Financial

Is It Time To Reassess Visa (V) After Recent Share Price Weakness?

If you are wondering whether Visa is attractively priced or already fully valued, you are not alone. This article will walk through what the current share price might be implying. Visa recently closed at US$306.52, with returns of a 2.4% decline over 7 days, a 6.0% decline over 30 days, an 11.5% decline year to date, and an 11.7% decline over 1 year. The 3 year and 5 year returns sit at 42.3% and 46.8% respectively. Recent headlines around Visa have focused on its role in global payments,...
NYSE:BAH
NYSE:BAHProfessional Services

Is Booz Allen Hamilton (BAH) Pricing Overreacting To Recent Government Contract Headlines

If you are wondering whether Booz Allen Hamilton Holding is attractively priced today, you are not alone. Many investors are asking whether the current share price reflects its long term potential or short term noise. The stock last closed at US$74.26, with returns of a 6.4% decline over 7 days, a 27.4% decline over 30 days, a 12.5% decline year to date, a 32.3% decline over 1 year, a 17.7% decline over 3 years and a 2.6% gain over 5 years, which has changed how some investors may view its...
NYSE:CRS
NYSE:CRSAerospace & Defense

Is It Too Late To Consider Carpenter Technology (CRS) After A 93% One Year Rally?

If you are wondering whether Carpenter Technology's share price still reflects fair value after a strong run, you are not alone. The stock closed at US$385.04, with returns of 1.4% over 7 days, 14.7% over 30 days, 13.8% year to date and 93.0% over the past year, plus a very large gain over 3 and 5 years. Recent headlines around Carpenter Technology have focused on its role as a specialty materials supplier in aerospace and industrial markets, alongside broader interest in suppliers tied to...
NYSE:NKE
NYSE:NKELuxury

Evaluating Nike (NKE) Valuation After Recent Weak Share Price Performance

Recent performance snapshot NIKE (NKE) shares closed at US$63.09, with recent returns showing a 3.5% decline over the past day, broadly flat performance over the past week, and negative moves over the month and past 3 months. See our latest analysis for NIKE. At around US$63, NIKE’s recent 1 day and 1 month share price declines sit against a much weaker 1 year total shareholder return of 19.6% and a 5 year total shareholder return of 50.9%. This suggests momentum has been fading and investors...
NYSE:DD
NYSE:DDChemicals

A Look At DuPont (DD) Valuation After Recent Share Price Momentum And Undervaluation Signals

DuPont de Nemours (DD) has caught investor attention after a strong past 3 months, with the stock showing a 29.1% total return. Recent business metrics offer more context for that move. See our latest analysis for DuPont de Nemours. That recent 29.1% three month total return sits alongside a 13.5% one month share price gain and a 49.5% one year total shareholder return. This suggests momentum has been building around DuPont de Nemours at the current US$50.08 share price. If this kind of move...
NasdaqGS:WGS
NasdaqGS:WGSHealthcare

GeneDx Holdings (WGS) Q4 Loss Of US$17.7 Million Tests Bullish Profitability Narrative

GeneDx Holdings (WGS) closed out FY 2025 with Q4 revenue of US$121.0 million and a basic EPS loss of US$0.61, alongside net income excluding extraordinary items of a US$17.7 million loss. Over recent quarters the company has seen revenue move from US$95.6 million in Q4 2024 to US$121.0 million in Q4 2025, while quarterly basic EPS has ranged from a loss of US$0.31 in Q3 2024 to a gain of US$0.38 in Q2 2025 and back to a loss of US$0.61 in the latest period. This sets up a story in which...
NasdaqGS:PNTG
NasdaqGS:PNTGHealthcare

What Pennant Group (PNTG)'s Earnings After Prior Guidance Beat Means For Shareholders

The Pennant Group (NASDAQ: PNTG), a senior living and home health provider, recently reported earnings after market close, following a prior quarter in which it exceeded revenue expectations and issued full-year revenue guidance above analyst estimates. With analysts maintaining their forecasts and projecting very strong year-on-year revenue growth for the latest quarter, investor attention has focused on whether Pennant’s operating momentum and guidance can sustain this level of...
NasdaqGS:PECO
NasdaqGS:PECORetail REITs

Assessing Phillips Edison (PECO) Valuation After Recent Share Price Momentum

Why Phillips Edison (PECO) is Back on Investor Radars Phillips Edison (PECO) has quietly drawn fresh attention after recent gains over the month and past 3 months, prompting investors to reassess this grocery anchored shopping center owner and its current valuation. See our latest analysis for Phillips Edison. Phillips Edison’s recent momentum, with a 30 day share price return of 10.88% and year to date gain of 11%, sits alongside a 1 year total shareholder return of 14.39%, suggesting steady...
NYSE:IVZ
NYSE:IVZCapital Markets

Assessing Invesco (IVZ) Valuation After Recent Share Price Volatility

Invesco (IVZ) is back in focus after recent share price moves, with the stock down about 11% over the past month but up roughly 4% in the past 3 months. See our latest analysis for Invesco. The recent weakness, including a 4.76% 1 day share price decline and an 11.23% 30 day share price pullback to US$25.21, sits against a much stronger 48.94% 1 year total shareholder return. This suggests that momentum has cooled after a solid run. If this volatility has you looking beyond asset managers, it...
NYSE:KR
NYSE:KRConsumer Retailing

What Kroger (KR)'s CEO Change and New Partnerships Strategy Means For Shareholders

Kroger recently appointed Greg Foran as Chief Executive Officer and expanded its initiatives through EVgo fast-charging installations, Home Chef’s Giada De Laurentiis collaboration, and enhanced Verified Savings support for SNAP customers. Together, these moves highlight Kroger’s emphasis on leadership stability, convenience-focused partnerships, and value offerings aimed at deepening customer loyalty across its grocery ecosystem. We’ll now examine how Greg Foran’s appointment as CEO may...
NasdaqGM:ACMR
NasdaqGM:ACMRSemiconductor

Is Seldon’s Stake Cut Amid ACMR’s Expansion Plans Altering The Investment Case For ACM Research (ACMR)?

Earlier in 2026, Seldon Capital disclosed a US$6.83 million sale of 183,242 ACM Research shares, markedly reducing its ownership position as the company tightened its 2025 revenue outlook and outlined expectations for continued growth in 2026. This combination of a major shareholder stepping back while ACM Research scales revenue toward the billion-dollar level and invests in new U.S. capacity highlights a tension between institutional positioning and management’s expansion plans. Next,...
NasdaqGS:INCY
NasdaqGS:INCYBiotechs

Is It Time To Reassess Incyte (INCY) After A 36% One-Year Share Price Gain?

If you are wondering whether Incyte at around US$100.85 is priced for its future or leaving some value on the table, this article walks through what the numbers are really saying about the stock. Over the past week Incyte declined 0.3%. Over 30 days it declined 1.1%. Over the last year it returned 36.3%, with 3-year and 5-year returns of 31.6% and 26.6% respectively. These figures can naturally raise questions about where it sits on the risk and reward spectrum today. Recent headlines around...
NYSE:DGX
NYSE:DGXHealthcare

How Investors May Respond To Quest Diagnostics (DGX) Earnings Beat, Higher Dividend And Expansion Plans

In February 2026, Quest Diagnostics reported higher fourth-quarter and full-year 2025 sales and earnings, issued 2026 guidance calling for US$11.70–US$11.82 billion in revenue and US$9.45–US$9.65 in diluted EPS, raised its quarterly dividend to US$0.86 per share, and disclosed continued share repurchases under its long-running buyback program. The company also signaled continued expansion by pursuing hospital outreach and independent lab acquisitions, while using its questhealth.com platform...
NYSE:FLO
NYSE:FLOFood

How Investors May Respond To Flowers Foods (FLO) Dividend Hike Amid Losses And Boardroom Turnover

Flowers Foods, Inc. recently reported Q4 2025 results showing sales of US$1,232.86 million but a net loss of US$67.07 million, driven in part by a US$135.98 million impairment of intangible assets, while also issuing 2026 sales guidance of US$5.16 billion to US$5.27 billion, indicating a 1.8% to 0.2% change from the prior year. Despite weaker profitability and upcoming retirements of long-serving directors George E. Deese and Edward J. Casey, Jr., the board approved a 3.1% increase in the...
NYSE:FUBO
NYSE:FUBOInteractive Media and Services

Evaluating FuboTV (FUBO) Valuation After Steep Share Price Pressure And Discounted Sales Multiple

FuboTV stock after recent performance FuboTV (FUBO) has been under pressure recently, with the share price at US$1.18 and negative returns over the past week, month, past 3 months and year to date drawing fresh attention from investors. See our latest analysis for FuboTV. The recent 1 day share price return of a 4.84% decline adds to a 30 day share price return of a 52.42% decline and a year to date share price return of a 54.44% decline, which points to fading momentum as investors reassess...
NasdaqGS:BEAM
NasdaqGS:BEAMBiotechs

Beam Therapeutics Taps US$500m Non Dilutive Debt To Back Risto Cel

Beam Therapeutics entered a long term, non dilutive financing agreement with Sixth Street to support the potential launch of its sickle cell gene therapy. The deal provides access to up to $500 million in capital tied to Beam’s commercial plans for this program. The agreement focuses on funding potential product launch and commercialization activities rather than issuing new equity. For investors watching NasdaqGS:BEAM, this financing move comes with the stock trading around $28.33 and a...